Monoclonal Anti-Human CD28 Antibody, premium grade

Monoclonal Anti-Human CD28 Antibody, premium grade (CD8-M120b) is recombinantly produced from human 293 cells (HEK293) .

Product Specifications

Background

T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2) . When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs) . The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.

CAS Number

9007-83-4

Host

HEK293

Origin Species

Mouse

Target

CD28

Conjugation

Unconjugated

Tag

Mouse IgG1 | Mouse Kappa

Stability

2-8°C for 12 months under sterile conditions; -70°C for 24 months. For long term storage, the product should be stored at liquid state at -70°C.

Endotoxin

0.002 EU per μg

Purity

0.95

Bioactivity

Immobilized Human / Cynomolgus / Rhesus macaque CD28, His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) with a linear range of 0.098-1.563 ng/mL (QC tested).